Intracranial Stenosis Stents Market To Reach USD 1.1 Billion By 2030


 

Intracranial Stenosis Stents Market Growth & Trends

The global intracranial stenosis stents market size is expected to reach USD 1.1 billion by 2030 and is expected to expand at 4.8% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Stroke is a leading cause of death and morbidity in the U.S. as well as globally. Large artery atherosclerosis is responsible for approximately 20% of all ischemic strokes, with nearly 50% of them being intracranial, and the condition has a comparatively high recurrence rate, regardless of medical treatment.

Furthermore, nearly 10% of ischemic strokes in the U.S. and up to 50% in Asia are caused by intracranial stenosis. The actual incidence of Intracranial Atherosclerotic Disease (ICAD) might be greater because symptomatic, non-stenosing atherosclerotic plaques may go undiagnosed with the current diagnostic methods. As per a study report, an autopsy analysis of stroke patients showed a significant number of intracranial non-stenosing atherosclerotic plaques, approximately 6% of which had superimposed thrombi and were presumed to be accidental results of an ischemic event.

Moreover, compared to Americans, Hispanics, Africans & Asians have higher rates of ICAD. The disparity in ICAD prevalence by race and ethnicity is probably caused by variations in risk factor profiles, dietary habits, and genetic predispositions. For instance, a study attributed the higher prevalence of hypertension, hyperlipidemia, and diabetes mellitus in African American patients to the high prevalence of ICAD.

A few major advantages of minimally invasive procedures include:

  • These procedures cause less discomfort and postoperative pain
  • Unlike conventional surgeries that make use of large openings, minimally invasive procedures rely on small openings
  • Minimally invasive procedures result in a shorter hospital stay
  • These procedures result in fewer scars

As per a research study on 169 patients, published in the Radiological Society of North America, 20 individuals (11.8%) faced complications. 10.5% of the individuals had a stroke (4 patients had symptomatic intracranial hemorrhages [ICHs]; 6 patients had an ischemic stroke) and two of these patients died. Two patients had asymptomatic ICHs and one had a transient ischemic attack, while the other had an asymptomatic dissection.

In Europe, there have been concerns about the shortage of skilled professionals in interventional neuroradiology. For instance, a study published in the European Journal of Neurology in 2018 found that there is a need for more training programs and resources to support the development of expertise in this area. The study also found that the shortage of skilled professionals can limit access to specialized treatments, such as intracranial stenosis stenting, for patients with neurological disorders.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/intracranial-stenosis-stents-market-report

Intracranial Stenosis Stents Market Report Highlights

  • Self-expanding stents dominated the overall market with 34.9% of the revenue share in 2022. Intracranial stenosis self-expanding stents are designed to open the narrowed areas and improve the blood flow in the brain. These stents have proven to be an effective treatment option as they have a high success rate with a low complication rate
  • The hospital segment held the largest market share of 80.8% in 2022. Intracranial stenosis procedures are complicated and critical surgeries, which depend on high-quality durable equipment available in hospitals. However, increasing preference for minimally invasive endovascular procedures in hospitals has led to the rising adoption of intracranial stents for stenosis patients
  • Ambulatory surgical centers are anticipated to showcase the fastest growth rate over the forecast period. These facilities offer patients with shorter hospital stays, quality hospitalization in stroke units, and lower readmission rates
  • The growth of the market in North America can be attributed to the presence of advanced healthcare facilities in the region, an increasing preference for minimally invasive procedures, the rising prevalence of atherosclerosis & brain strokes, the growing geriatric population, and the presence of key industry players

Intracranial Stenosis Stents Market Segmentation

Grand View Research has segmented the global intracranial stenosis stents market based on product, end-use, and region: 

Intracranial Stenosis Stents Product Outlook (Revenue, USD Billion, 2018 - 2030)

  • Self-expanding Stents
  • Embolization Coil Support Intracranial Stents
  • Venous Sinus Stents
  • Balloon-expanding & Other Stents

Intracranial Stenosis Stents End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Intracranial Stenosis Stents Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

List of Key Players in the Intracranial Stenosis Stents Market

  • phenox GmbH
  • Medtronic
  • Acandis GmbH
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • CERENOVUS (Johnson & Johnson)
  • Sino Medical Sciences Technology, Inc.
  • Stryker
  • Balt

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/intracranial-stenosis-stents-market-report  

Comments

Post a Comment

Popular posts from this blog

Virtual Clinical Trials Market Size Reaches USD 12.9 Billion By 2030

Image
  The global  virtual clinical trials market  size is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth. There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical trials. Virtual clinical trials eliminate challenges posed by traditional clinical trials for example delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of people favored a mobile trial over traditional ones and 80.0% of patients are more likely to participate in a clinical trial that uses mobile technology. The market is recovering at a significant pace after the pandemic as ...
Read more

Flea, Tick And Heartworm Products Market To Reach USD 10.90 Billion By 2030

Image
  Flea, Tick And Heartworm Products Market Growth & Trends The global  flea, tick and heartworm products market  size is expected to reach USD 10.90 billion by 2030, registering a CAGR of 7.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing an upsurge in developing and launching innovative products. These products can effectively manage parasitic complications in cats & dogs and prove to be a useful parallel option for treatment for pet owners and veterinarians. One such prominent example is flea & tick control collars. These products are just like normal pet collars but contain a specific drug capable of repelling the infestation of fleas, ticks and mosquitoes for some time.  Apart from Seresto by Elanco, other emerging and established players are actively investing in the development of similar collars but utilize novel approaches to enhance infestation control. These launches can also be consider...
Read more

Wheat Market Size, Share, Trends And Industry Outlook Report, 2030

Image
  Wheat Market Growth & Trends The global  wheat market  size has been estimated to reach USD 270.88 billion by 2030 and is anticipated to expand at a CAGR of 4.28% from 2024 to 2030, according to a new report by Grand View Research, Inc. A rapid shift in dietary preferences and fast-evolving consumption habits are playing a pivotal role in the rising demand for organic food products, thereby intensifying the global requirement for wheat. Additionally, the increasing popularity of processed and convenient foods is fueling the demand for wheat-based products, leading to a surge in global wheat production. Conventional wheat accounted for a dominant market revenue share in 2023. The production of this type of wheat depends on the use of synthetic fertilizers and pesticides to achieve higher yields, effectively meeting the growing global wheat demand. Furthermore, the established supply chain present in conventional wheat farming ensures efficient distribution and widesp...
Read more